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ABSTRACT
Bypassing of DNA lesions by damage-tolerant DNA
polymerases depends on the interaction of these
enzymes with the monoubiquitylated form of the
replicative clamp protein, PCNA. We have analyzed
the contributions of ubiquitin and PCNA binding to
damage bypass and damage-induced mutagenesis
in Polymerase g (encoded by RAD30) from the
budding yeast Saccharomyces cerevisiae.
We report here that a ubiquitin-binding domain
provides enhanced affinity for the ubiquitylated
form of PCNA and is essential for in vivo function
of the polymerase, but only in conjunction with a
basal affinity for the unmodified clamp, mediated by
a conserved PCNA interaction motif. We show that
enhancement of the interaction and function in
damage tolerance does not depend on the ubiquitin
attachment site within PCNA. Like its mammalian
homolog, budding yeast Polymerase g itself is
ubiquitylated in a manner dependent on its
ubiquitin-binding domain.
INTRODUCTION
Replicative bypass of DNA damage by translesion
synthesis (TLS) is essential for the proliferation of cells in
the presence of genotoxic agents, but also to overcome
lesions caused by the spontaneous decay of DNA in an
aqueous environment (1,2). Replicative DNA polymerases
are poorly equipped for TLS, because their catalytic
centers are optimized for an unperturbed primer-template
junction. Most organisms, therefore, harbor specialized
damage-tolerant polymerases with more relaxed active
sites that can accommodate a variety of lesions in the
template strand (3–5). Conserved in both prokaryotes and
eukaryotes, the Y-family of DNA polymerases comprises a
group of enzymes dedicated to TLS (6). While the genome
of budding yeast encodes only two Y-family polymerases,
PolZandRev1,atleastfourdiﬀerentenzymeswithvarying
speciﬁcities and preferences for diﬀerent types of lesions
are available to human cells.
One inevitable consequence of their ability to synthesize
across DNA lesions is the overall reduced ﬁdelity of
TLS polymerases, even on undamaged templates (7).
The replicative bypass of DNA lesions therefore contri-
butes signiﬁcantly to the mutagenic eﬀect of DNA-
damaging agents (8), and it is not surprising that the
activity of the damage-tolerant polymerases is
tightly regulated in order to prevent the accumulation of
unwanted mutations due to unrestrained activity of these
error-prone enzymes. In eukaryotes, the principal mecha-
nism of damage-induced activation of TLS polymerases
involves the sliding clamp, proliferating cell nuclear
antigen (PCNA). PCNA acts as a processivity factor for
replicative polymerases, but also as a binding platform for
a large number of other proteins involved in the coordina-
tion of events at the replication fork (9). Many of these
proteins,includingsomeoftheY-familypolymerases, bind
PCNA via a conserved motif, termed PCNA interacting
peptide (PIP) (10). Covalent modiﬁcation of PCNA by
ubiquitin or SUMO was found to modulate the properties
of the clamp and to regulate access of alternative sets of
accessory factors to the site of replication (11–16).
Speciﬁcally, genetic studies indicate that PCNA
monoubiquitylation at lysine (K) 164 by the ubiquitin-
conjugating enzyme (E2) Rad6 and the ubiquitin ligase
(E3) Rad18 is a prerequisite for the activation of
all damage-tolerant polymerases in yeast (15), and
preferential interactions of TLS polymerases PolZ, Polk,
Poli and Rev1 with the modiﬁed form of the clamp
have now been demonstrated in mammalian cells
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explains the recruitment of damage-tolerant polymerases
to stalled replication forks by means of PCNA
ubiquitylation.
The identiﬁcation of two novel types of ubiquitin-
binding domains (UBDs), termed UBM and UBZ (18),
has recently uncovered the molecular basis for the
observed enhancement of PCNA binding by ubiquityla-
tion. These motifs are present in one or two copies in all
the mammalian Y-family polymerases and were found to
directly bind ubiquitin in vitro. As they reside outside the
catalytic domains, they do not aﬀect polymerase activity
of the TLS enzymes, but rather act by modulating
their interactions and localization (18,20). Interestingly,
they are also responsible for the ubiquitylation of the
polymerases themselves, a phenomenon whose signiﬁ-
cance is not yet understood, but is characteristic for other
ubiquitin-binding proteins as well (18–20).
PolZ is a Y-family polymerase conserved in yeast and
mammals, with a strong preference for cyclobutane
pyrimidine dimers (CPDs) induced by ultraviolet (UV)
radiation (21,22). It inserts the correct nucleotides opposite
a thymine CPD, but is less eﬃcient and highly inaccurate in
the bypass of other lesions (23–26). In humans, defects in
PolZ result in a hereditary disease, Xeroderma pigmento-
sum variant (XP-V), involving photosensitivity and a
predisposition to skin cancer (22,27). PCNA stimulates
the activity of PolZ without enhancing its processivity, and
a PIP domain at the carboxy (C)-terminus of the protein
(Figure 1A, B) was found to be required for interaction
with the clamp and function in vivo (28). A UBZ domain
was identiﬁed in the C-terminal region of human PolZ
(Figure 1A, C) and shown to convey ubiquitin binding and
recruitment to damage-induced nuclear foci (18,20).
Expression of a PolZ allele carrying a point mutation in
the UBZ domain failed to fully complement the UV
sensitivity of XP-V cells without aﬀecting polymerase
activity, indicating that an intact UBZ domain is required
for PolZ function in vivo (18).
In PolZ and Polk, the UBZ domains are characterized
by a mononuclear Zinc ﬁnger (UBZ) of the C2H2 or C2HC
type, respectively (18). The corresponding sequence within
budding yeast PolZ, encoded by the RAD30 gene (29,30),
diﬀers considerably from that of the mammalian homo-
log, and one of the conserved cysteine residues is replaced
by a tyrosine (Figure 1C). Moreover, we were unable to
detect binding of a recombinant C-terminal fragment
comprising the putative UBZ domain and the PIP motif,
or of full-length Rad30 from total yeast cell lysate, to free
ubiquitin or ubiquitin chains (our unpublished results).
We have therefore examined the relevance of the putative
UBZ domain for physical interactions with the modiﬁed
clamp and biological function of PolZ in Saccharomyces
cerevisiae. We show here that the domain fulﬁlls the
expected function in yeast, but only in conjunction with an
intact PIP domain. In addition, we have characterized the
requirements for ubiquitylation of PolZ itself, and we
provide evidence that the exact molecular arrangement of
ubiquitin and PCNA is not critical for recruitment of PolZ
and eﬀective damage bypass in vivo.
MATERIALS AND METHODS
Yeast strains and plasmids
Standard procedures were followed for the cultivation and
manipulation of S. cerevisiae. Unless otherwise noted,
yeast strains (rad30::HIS3, rad5::HIS3, rad18::TRP1,
rad6::HIS3, rev1::URA3, rev3::KanMX and appropriate
combinations) are derived from DF5 and have been
described previously (31). For genetic analysis of mutants
Figure 1. Structure of PolZ and the constructs used in this study.
(A) Domain structure of PolZ, indicating the positions of the
polymerase domain (POL), the UBZ domain and the PCNA-interacting
peptide (PIP), numbered according to the budding yeast protein. (B)
Sequence alignment of PolZ PIP domains from human (H. s.), mouse
(M. m.) and budding yeast (S. c.). A dash indicates a gap in the
alignment. The PIP* mutant was generated by changing the two
conserved phenylalanine residues (indicated by an asterisk) to alanine.
This change is known to disrupt the interaction with PCNA without
aﬀecting the overall structure of the protein (28). (C) Sequence
alignment of PolZ UBZ domains. Conserved cysteine and histidine
residues are shaded in black. The conserved aspartate residue indicated
by an asterisk was changed to alanine in order to create
the UBZ* mutant in analogy to the mammalian protein (18).
(D) Structure of the linear fusions of ubiquitin and PCNA used
for analysis of protein–protein interactions and in vivo function.
Mutations that prevent ubiquitin polymerization, conjugation and
processing are indicated above and sequences of the linker peptides
below each construct.
882 Nucleic Acids Research, 2007, Vol. 35, No. 3in the RAD30 gene, a rad30 or rad30 rad5 deletion strain
was transformed with shuttle vectors based on YIplac128
(32), which carried the WT or mutated RAD30 open
reading frame (ORF) under the control of the endogenous
RAD30 promoter, for integration into the LEU2 locus.
The empty vector YIplac128 served as a negative control.
The RAD30 vectors were constructed by inserting a PCR
product comprising the ORF (SmaI-PstI) ﬂanked by
500bp of RAD30 upstream region (SacI-SmaI) and a
transcription terminator derived from pGBT9 (Clontech,
PstI-SphI). Mutations in the UBZ (D570A) and/or PIP
motif (FF627/628AA) were introduced by PCR-based
mutagenesis. All constructs were sequenced throughout
the ORF. For two-hybrid analysis, the ORFs were
subcloned into the vectors pGAD424 and pGBT9
(Clontech). In addition, a truncated version of RAD30
encoding amino acids 538–632 was constructed. The
ORFs of pol30(K127/164R), ubiquitin and the fusion
constructs shown in Figure 1D were assembled by PCR
and cloned (Ub*-PCNA*: BamHI-PstI; PCNA*-Ub*:
SmaI-PstI) into the two-hybrid vectors, into pQE30, and
into YIplac128 under control of the POL30 promoter, in
analogy to the expression vector for PCNA described
previously (15). For detection of PolZ on western blots,
a sequence encoding the 9myc-epitope was appended to
the RAD30 ORF as described (31). For in vivo pull-down
experiments, a sequence encoding His7-tagged ubiquitin
was generated by PCR and cloned (BamHI-PstI) into an
episomal plasmid based on YEplac181 or YEplac195 (32),
under control of the CUP1 promoter (428bp of upstream
sequence, SacI-BamHI) and the transcription terminator
from pGBT9 (PstI-SphI).
Two-hybrid analysis
Analysis of protein–protein interactions in the two-hybrid
system was performed in PJ64-4A, as described previously
(32). Selection for the presence of the bait and prey
plasmids was carried out on synthetic medium lacking
tryptophan and leucine, and positive interactions were
scored by growth on medium further lacking histidine or
histidine and adenine.
Measurements ofUV sensitivities and UV-induced mutation
frequencies
UV sensitivities were determined by plating deﬁned
numbers of cells onto YPD medium, irradiation at
254nm in a UV crosslinker (Stratalinker 2400 by
Stratagene), incubation in the dark for 3 days, and
colony counting. UV-induced mutation frequencies in
the CAN1 locus were measured similarly by comparing the
numbers of can1
R mutants at a given UV dose, selected on
synthetic medium without arginine containing 30mg/ml
canavanine, with the numbers of survivors on YPD
exposed to the same UV dose. Standard deviations were
calculated from triplicate measurements.
In vivoanalysis of yeast proteins
Total cell lysates were prepared as described (33). PCNA
and the fusion constructs were detected by western blot
with an anti-Pol30 antibody (15). For detection of PolZ
modiﬁcation, strains bearing 9myc-tagged RAD30
(WT, rad6, rad18 or rad30 mutants) were transformed
with an episomal vector encoding His7-tagged ubiquitin
(see above). Cultures were grown in selective medium
containing 0.1mM CuSO4. Pull-downs on Ni-NTA
agarose from total lysates were performed under denatur-
ing conditions as described previously (11,15), and the
Rad30 protein was detected by western blot using a
monoclonal anti-myc antibody (Santa Cruz
Biotechnology). Detection of phosphoglycerate kinase
(PGK) with a monoclonal antibody (Molecular Probes)
served as loading control.
Invitro analysis of protein interactions
Recombinant PCNA*, Ub*-PCNA* and PCNA*-Ub*
were produced in E. coli by expression from pQE30 with
an N-terminal His6-epitope. Proteins were puriﬁed by
chromatography on Ni-NTA agarose and dialyzed against
a buﬀer containing 25mM Tris-HCl, pH 7.5, 50mM NaCl
and 10% glycerol. Gel ﬁltration analysis was performed at
2mM PCNA on a Superdex 200 column as described (34).
In vitro pull-down assays with GST fusion proteins were
performed by immobilizing the GST-PCNA fusion
protein (13) on glutathione Sepharose, incubation with
the respective binding partner for 30min at 308Ci n
phosphate-buﬀered saline with 0.05% Triton X-100,
washing three times with the same buﬀer and eluting
bound material by boiling in SDS sample buﬀer.
RESULTS
UBZandPIPmotifsjointlycontributetointeractionofyeast
Polgwith ubiquitylated PCNA
In order to analyze the interactions between PolZ and
ubiquitylated PCNA in the two-hybrid system, we
constructed linear fusions of ubiquitin to the amino
(N)- and the C-terminus of PCNA, respectively
(Figure 1D). The lysine residues within PCNA and the
ubiquitin moiety known to be involved in ubiquitin or
SUMO conjugation were mutated to arginine to prevent
further modiﬁcation, and the C-terminus of ubiquitin was
altered in order to prevent processing by isopeptidases or
conjugation to other proteins. Using isolated ubiquitin
(Ub*) and PCNA (PCNA*) carrying the same mutations
as controls, these constructs were examined for binding to
wildtype (WT) Rad30 or variants in which the PIP and/or
the UBZ motif were inactivated by point mutations
(Figure 1B, C). When PCNA* was fused to the GAL4
activation domain (AD) and Rad30 to the DNA-binding
domain (BD), interaction depended on an intact PIP
domain in Rad30 and was strong enough to activate the
HIS3-, but not the ADE2 reporter in the two-hybrid
system (Figure 2A, upper panel). Stronger signals with
both reporter genes were observed with the two fusion
constructs Ub*-PCNA* and PCNA*-Ub*. These interac-
tions were aﬀected by both PIP and UBZ domains.
Mutation of either resulted in weakening of the interaction
to the level of the interaction with PCNA*, and mutation
of both completely abolished the signal. Reversal of the
orientation in the two-hybrid system resulted in overall
Nucleic Acids Research, 2007, Vol. 35,No. 3 883weaker signals: interaction was only visible with the
fusions and depended on both UBZ and PIP (Figure 2A,
lower panel). Very similar results were obtained with a
C-terminal domain of Rad30 comprising the UBZ and
PIP motifs (Figure 2B).
Notably, interaction with ubiquitin alone or a fusion of
ubiquitin to an unrelated protein such as GFP (data not
shown) was never observed in our system. Taken together,
these ﬁndings suggest that the UBZ domain of PolZ from
budding yeast does contribute to ubiquitin binding, but
this association is unlikely to be strong and may be
eﬀective only in conjunction with a basal aﬃnity of Rad30
for PCNA, mediated by the PIP motif. Naturally, neither
the two-hybrid system nor the linear fusions of ubiquitin
and PCNA fully reﬂect the physiological arrangement of
the interaction partners, which makes quantitative state-
ments problematic. Nevertheless, it is noteworthy that the
exact position of ubiquitin on PCNA was irrelevant in this
context, such that UBZ-dependent enhancement of PCNA
binding was detectable even though ubiquitin was not
attached to its natural position, K164.
The UBZ domain isrequired forPolZfunction in translesion
synthesis
Having obtained evidence for a contribution of the UBZ
domain to ubiquitin binding, we analyzed the conse-
quences of mutations in this domain for the function of
Rad30 in DNA damage tolerance. Since the Rad30
protein, like human PolZ, is largely selective for the
bypass of UV-induced CPDs, we used UV radiation as a
damaging agent. Mutation of the UBZ domain resulted in
a UV sensitivity close to that of a rad30 deletion or a
mutant in the PIP motif (Figure 3A). Similar results were
obtained in a rad5 background, where overall UV
sensitivities are exacerbated due to the abolishment of
error-free damage avoidance (Figure 3B). In this back-
ground, the rad30(PIP*) mutant displayed a substantial,
but not complete loss of function, which is consistent with
previous results that have demonstrated a somewhat
milder phenotype for modiﬁcation by point mutations as
compared to deletion of the PIP motif in this background
(28). These results demonstrate a contribution of the
Rad30 UBZ domain to resistance towards UV-induced
DNA damage.
An alternative way of assessing the function of RAD30
in lesion bypass is the measurement of damage-induced
mutation frequencies in a strain that is dependent on TLS
for damage bypass because the error-free damage
avoidance pathway has been inactivated. MacDonald
et al. have shown that in a rad5 background, deletion of
RAD30 results in a massive increase in UV-induced
reversion frequencies (29), presumably due to the
processing of lesions by error-prone, Polz- and/or
Rev1-dependent TLS in the absence of error-free,
PolZ-dependent bypass. This provides a sensitive tool to
monitor the contribution of RAD30 to error-free TLS.
When we determined forward mutation frequencies in the
CAN1 locus in response to UV irradiation (Figure 3C),
we found that rad30(UBZ*) aﬀorded mutation frequen-
cies comparable to those of the rad30 deletion, consistent
with a complete loss of function, whereas rad30(PIP*)
retained some residual activity. Again, these data provide
evidence for an absolute requirement of the UBZ domain
in yeast PolZ.
LinearfusionsofubiquitinandPCNAcanpartiallysubstitute
forloss ofPCNA ubiquitylation
In order to determine whether the linear fusions between
ubiquitin and PCNA reﬂected the physiological situation of
naturally ubiquitylated PCNA to any degree, we examined
their properties in vivo and in vitro. Figure 4A shows that
the fusion proteins did not rescue the lethality of a pol30
Figure 2. Physical interactions between Rad30, PCNA and ubiquitin.
Interactions were monitored in the two-hybrid system, based on fusions
to the GAL4 activation (AD) and DNA-binding (BD) domains.
Presence of the respective constructs was ensured by selection on
plates lacking leucine and tryptophane (-LW), and interactions were
scored by growth on plates lacking histidine or histidine and adenine
(-HLW, -AHLW). (A) Interaction of Rad30 (WT) and the indicated
mutants with PCNA*, ubiquitin (Ub*) and the linear fusions shown in
Figure 1D. PCNA* and Ub* were mutated in the same manner as the
fusion constructs. (B) same as in (A), but using an N-terminally
truncated version of Rad30, comprising amino acids 538–632.
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promoting DNA replication, are aﬀected by attaching
ubiquitin to its N- or C-terminus. However, gel ﬁltration
analysis of the puriﬁed proteins indicated that both Ub*-
PCNA* and PCNA*-Ub* exist as relatively stable homo-
trimers in solution, suggesting that the failure to support
viability is not caused by a lack of trimerization (Figure
4B). Two-hybrid and in vitro pull-down assays showed that
the fusion proteins can interact not only with themselves,
but also with native PCNA* (Figure 4C, D). Thus,
coexpression of the fusions with endogenous PCNA
should result in the formation of mixed trimers, which
could potentially take over the function of physiologically
ubiquitylated PCNA in a strain unable to ubiquitylate
endogenous PCNA, such as a rad18 mutant. We, therefore,
expressed the two constructs, Ub*-PCNA* and PCNA*-
Ub*, under the control of the POL30 promoter from an
integrative vector in a rad18 strain (Figure 5A). As a
control, we expressed unmodiﬁed pol30(K127/164R)
(PCNA*) to the same level, as it has previously been
shown that overexpression of POL30 or pol30(K164R)
suppresses the damage sensitivity of rad18 mutants to some
extent (11). We found that fusion of ubiquitin to the N- or
C-terminus of PCNA signiﬁcantly enhanced its ability to
suppress the UV sensitivity of a rad18 mutant, whereas
it had no eﬀect in a WT background (Figure 5B). As
expected, suppression was incomplete, consistent with the
notion that the fusion proteins cannot be further ubiqui-
tylated, which eliminates the error-free, polyubiquitin-
dependent pathway of damage avoidance. In order to
demonstrate that the observed suppression was in fact due
to TLS, we reexamined UV sensitivities in a rad18 mutant
that additionally carries deletions of the genes encoding the
TLS polymerases, REV1, REV3 and RAD30.I nt h i s
mutant (rad18 DTLS), expression of the fusion constructs
had no eﬀect on survival of DNA damage, indicating
that Ub*-PCNA* and PCNA*-Ub* indeed exert their
inﬂuence by means of the TLS polymerases. The enhanced
UV sensitivity observed in the rad18 DTLS strain compared
to rad18 may be due to functions of REV3 independent of
PCNA ubiquitylation (34,35). Taken together, these results
indicate that linear fusions of ubiquitin and PCNA can
partially substitute for the loss of endogenously ubiquity-
lated PCNA in DNA damage tolerance, and they suggest
that the constructs used for interaction studies reﬂect the
physiological situation to some degree.
Polgis ubiquitylated in vivoinaRAD6- and RAD18-
independent manner
Ubiquitylation of UBD-containing proteins in a
UBD-dependent manner has been observed previously
(36,37), and mammalian PolZ, Polt and Rev1 were all
found to be ubiquitylated in vivo (18,19). For detection of
yeast PolZ, we appended a 9myc-epitope to the protein’s
C-terminus (Figure 6A). On western blots, a faint band of
higher molecular weight suggested a modiﬁed form. As
shown in Figure 6B, Rad30
9myc was detected in Ni-NTA
pull-downs performed under denaturing conditions from
cells expressing His-tagged ubiquitin, suggesting that the
modiﬁcation was indeed monoubiquitin. We were inter-
ested to see whether ubiquitylation of PolZ required any
of the same conjugation factors that operate on PCNA,
i.e. Rad6 and Rad18 (11). Figure 6B shows that the levels
of modiﬁed Rad30
9myc were unchanged in the rad18
mutant and only marginally reduced in rad6, suggesting
that either a diﬀerent E2-E3 pair is responsible for the
modiﬁcation, or that the UBZ domain functions in an
autocatalytic manner and aﬀords modiﬁcation indepen-
dent of any additional E3 and not entirely relying on Rad6
as an E2. Relevance of the UBZ domain for Rad30
9myc
modiﬁcation was conﬁrmed by a signiﬁcant reduction in
ubiquitylation of the UBZ* mutant (Figure 6C). In
contrast, interaction with PCNA was dispensable, because
modiﬁcation of the PIP* mutant was comparable to that
of WT Rad30
9myc (Figure 6C). Moreover, we did not
observe an eﬀect of DNA damage, suggesting that
Figure 3. The Rad30 UBZ domain is required for PolZ-dependent error-free bypass of UV damage in yeast. (A) Eﬀect of UBZ and PIP domain
mutations on sensitivities towards UV radiation. Strains bearing a rad30 deletion were complemented with WT RAD30 or mutants in the UBZ
and/or PIP domain on integrative vectors. The empty vector served as control. (B) same as in (A), but using a rad5 rad30 deletion background.
(C) UV-induced forward mutation frequencies in the CAN1 locus. Constructs used: RAD30 (squares), rad30, i.e. empty vector
(inverted triangles), rad30(UBZ*) (circles), rad30(PIP*) (triangles), rad30(UBZ* PIP*) (diamonds). Filled symbols indicate RAD5, open symbols
a rad5 background.
Nucleic Acids Research, 2007, Vol. 35,No. 3 885ubiquitylation of PolZ in S. cerevisiae may not be
regulated via the DNA damage response (Figure 6B).
Thus, the physiological signiﬁcance of this modiﬁcation is
still unclear.
DISCUSSION
Our analysis of the UBZ motif of budding yeast PolZ has
revealed several parallels to the corresponding domain in
its mammalian ortholog, but we have also made observa-
tions that will help generalize our understanding of UBDs
in eukaryotic Y-family polymerases.
Ubiquitin binding by theUBZ domain
We have shown that, despite its variation in primary
sequence, the UBZ domain from yeast PolZ is functional
in ubiquitin binding and contributes to an enhanced
association of the polymerase with ubiquitylated PCNA.
However, neither full-length yeast PolZ nor its UBZ
domain alone exhibited signiﬁcant aﬃnity for isolated,
unconjugated ubiquitin. This situation diﬀers from the
mammalian system, where UBZ domains were ﬁrst
isolated by means of interaction with free ubiquitin
in a two-hybrid screen, and the UBZ of PolZ promoted
binding to ubiquitin agarose in the context of the
full-length polymerase (18). This suggests that the inter-
action of the yeast UBZ domain with ubiquitin might be
weaker or more transient, possibly due to its divergent
sequence, thus requiring a PIP-mediated basal aﬃnity for
PCNA as an obligatory interaction partner.
In mammalian PolZ, the relative contributions of PIP
and UBZ domains to binding of ubiquitylated PCNA
have not been analyzed. In human Poli, however,
inactivation of the functionally related UBM domains
had a much more severe eﬀect on the aﬃnity to a PCNA-
ubiquitin fusion than mutation of the PIP domain (18),
and in the Rev1 protein, constitutive damage-independent
association with PCNA at replication foci was found to
require an N-terminal BRCT domain (38), whereas the
damage-induced enhancement of binding to the ubiquity-
lated clamp was mediated by the UBM domains (19).
Thus, it appears that UBDs may vary substantially in their
aﬃnities to ubiquitin and might, therefore, not
always function autonomously in their recognition of
ubiquitylated target proteins.
Function of theUBZ domain inTLS
The single amino acid substitution introduced into the
UBZ motif to abolish ubiquitin binding does not prevent
the interaction of the mutated protein with unmodiﬁed
Figure 4. Properties of permanently ubiquitylated PCNA. (A) Fusions of PCNA to ubiquitin cannot rescue the lethality of a pol30 deletion. The
linear fusion constructs of ubiquitin and PCNA shown in Figure 1D or a construct for expression of pol30(K127/164R) (PCNA*) under control
of the POL30 promoter or an empty vector (‘‘–‘‘) were integrated in a pol30 strain expressing WT POL30 on a centromeric plasmid bearing the
URA3 marker. Growth on plates containing 5-ﬂuoroorotate (5-FOA) indicates viability after loss of the plasmid. The rare colonies arising from Ub*-
PCNA* and PCNA*-Ub* on 5-FOA were analyzed by western blot and found to have maintained expression of PCNA despite loss of the URA3
marker. (B) Gel ﬁltration analysis shows that Ub*-PCNA* and PCNA*-Ub* form homotrimers in solution with a stability approaching that of
native PCNA*. A non-lethal allele defective in trimerization (PCNA-52) (47) was analyzed for comparison. Proteins were produced in E. coli with an
N-terminal His6 epitope. An arrow indicates the void volume of the column. (C) Interaction of the PCNA constructs used in (B) in the two-hybrid
system. (D) Subunit exchange between GST-PCNA and His6-tagged Ub*-PCNA* or PCNA*-Ub* in vitro. GST-PCNA was immobilized on
glutathione Sepharose and incubated with the His6-tagged fusion protein, and bound material was analyzed by western blot (anti-His).
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this situation would be diﬀerent in the case of chromatin-
bound PCNA. Thus, the functions of the PIP and the
UBZ motifs appear to be separable. Yet, analysis of
damage sensitivities and mutation frequencies demon-
strates that both domains are absolutely required
for function in damage bypass and prevention of
damage-induced mutagenesis in yeast PolZ. Phenotypic
analysis of human PolZ was more ambiguous with respect
to the relative importance of each motif (18).
This absolute requirement for both PCNA and ubiquitin
binding resembles the phenotype of yeast rev1 mutants in
the BRCT and the UBM domains, which are both inactive
with respect to TLS and damage-induced mutagenesis
(19,38). Thus, analysis of the yeast proteins in
the context of damage bypass can prove valuable when
loss-of-function mutants in some of the mammalian
Y-family polymerases are poorly accessible to genetic
studies.
Flexibility in thesite of ubiquitin attachment
Our study has shown that monoubiquitin attached to the
N- or C-terminus of PCNA can partially overcome the
need for PCNA ubiquitylation at its physiological site,
K164, in mediating UBZ-dependent interaction with PolZ
in the two-hybrid system and also in terms of biological
function in the context of TLS. Precedents for the
functionality of linear fusion constructs have been
reported for targets of ubiquitin as well as SUMO
conjugation (39–42), but in many of these cases more
than one lysine within the target protein can naturally
serve as acceptor for the modiﬁer. Given that both in vivo
and in vitro PCNA is ubiquitylated exclusively at K164
(11,43), a redundancy in the positioning of the modiﬁer is
surprising. In molecular terms, simultaneous interactions
involving both the UBZ domain and the PIP motif, which
is known to interact with a region involving the
interdomain connector loop of PCNA (44,45), must
therefore involve signiﬁcant ﬂexibility either on the side
of PolZ itself or in the linkage between the C-terminus of
ubiquitin and K164 of PCNA. Thus, in the case of PCNA,
the ubiquitin acceptor site might reﬂect an arbitrary
preference of the conjugating enzymes rather than a
condition for functionality of the modiﬁed clamp.
Considering that the fusion proteins cannot substitute
for PCNA with respect to its essential function in DNA
replication, however, K164 might also be one of a limited
Figure 6. Budding yeast PolZ is modiﬁed by monoubiquitin. (A) Detection of Rad30
9myc in a total cell lysate by western blot (anti-myc). A band of
higher molecular weight, which might represent ubiquitylated Rad30
9myc, is indicated by an asterisk. (B) Monoubiquitylation of Rad30 does not
depend on RAD6, RAD18 or UV damage. Ubiquitylated Rad30
9myc protein was detected by western blot (anti-myc) after isolation of total
ubiquitylated proteins under denaturing conditions from a strain bearing His-tagged ubiquitin. Strains with untagged Rad30 or untagged ubiquitin
were used as controls. The top panel shows the ubiquitylated Rad30
9myc protein isolated by pull-down of His-ubiquitin, while the bottom panel
shows the levels of Rad30
9myc in the corresponding total cell extracts. (C) Monoubiquitylation of Rad30 depends on the UBZ*, but not on the PIP*
domain mutant. A 9myc-epitope was appended to the mutant rad30 alleles in the strains used in Figure 3, and ubiquitylated Rad30
9myc was isolated
and detected as in (B).
Figure 5. In vivo function of permanently ubiquitylated PCNA.
(A) Detection of PCNA by western blot (anti-Pol30) in total lysates
from cells expressing the constructs described in the legend to Figure 4
in addition to endogenous PCNA. Detection of phosphoglycerate
kinase (PGK) was used as loading control. (B) UV sensitivities of the
strains shown in (A): ‘‘–‘‘, i.e. empty vector (squares), PCNA* (circles),
Ub*-PCNA* (triangles), PCNA*-Ub* (diamonds). Filled symbols
indicate WT host strains, open symbols a rad18 background. (C)U V
sensitivities in the rad18 rad30 rev1 rev3 (rad18 DTLS) background,
labeled as in (B).
Nucleic Acids Research, 2007, Vol. 35,No. 3 887number of sites within the PCNA molecule that allows
modiﬁcation without disrupting vital interactions with
other cellular factors.
Autoubiquitylation ofubiquitin-binding proteins
Finally, ubiquitylation of PolZ appears to be conserved
across the species and is not unexpected in light of the
UBD-mediated modiﬁcation of many other monoubiqui-
tin-binding proteins, such as components of the endocytic
pathway (36,39,46). We have now shown that, in the case
of PolZ, this phenomenon is largely independent of the
conjugation factors responsible for the modiﬁcation of
PCNA or interaction with the clamp, but strongly
dependent on the UBZ domain itself, as in mammalian
PolZ. This suggests either an involvement of a diﬀerent set
of E2 and E3 enzymes, or possibly an autocatalytic action
of the UBD. In the latter scenario, the modiﬁcation could
result from interaction of the UBD with an activated
ubiquitin moiety loaded onto an E2 (or potentially an E1)
molecule, which would circumvent the need for a speciﬁc
E2–E3 pair. It is yet unclear whether this reaction would
be an inevitable consequence of the interaction between a
UBD and activated ubiquitin and thus an irrelevant side
reaction, or whether modiﬁcation of UBD-containing
proteins can serve as a regulatory strategy of blocking
their own ubiquitin-binding properties in an intramolec-
ular fashion (39). The inability of ubiquitylated mamma-
lian PolZ to bind ubiquitylated PCNA may suggest the
latter (18); however, we did not observe any change in the
extent of yeast Rad30 modiﬁcation in response to DNA
damage. Considering that the majority of PolZ in yeast
and mammals is not modiﬁed at any given time, it is
diﬃcult to imagine an eﬀective regulatory scenario by
modiﬁcation of the polymerase. Likewise, the apparent
absence of polyubiquitylated species argues against a
proteolytic function of PolZ modiﬁcation. In order to gain
insight into the relevance of this process, it will be
necessary to identify the sites of modiﬁcation and analyze
the consequences of the relevant mutations.
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